Sonder Capital Management, LLC
Sonder Futures II, L.P.
Open, writing first checks
Open: no first sale reported; age from Form D filed Jun 2023 (approximate)
- Vintage
- Unknown
- Fund size
- $225M (Form D)
- Stages
- Not stated
- Sectors
- Medical devices
- Regions
- Not stated
01 · Thesis
Sonder Capital backs medical innovation, building and funding medtech companies. Its team has invented, built, or funded medical innovations and creates new healthcare companies.Inferred from the firm's website
02 · Initial check
$2.25M to $3.75M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Kate Garrett, Co-Founder & Managing Partner
- Jay Watkins, Co-Founder & Partner
- M. Wood, Managing Director of the General Partner
- Frederic Moll, Managing Director of the General Partner
- Andy McGibbon, Managing Director of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideSonder Capital backs medical innovation, and its team has built and funded medtech companies.
Chances are that you or someone you love has been touched by a medical innovation our team has invented, built, or funded.
https://sondercapital.com/
06 · Sources
Last verified: Oct 28, 2026